Publications

Complete List of Hanh Lam Lab Publications on PubMed

Recent publications

UC Santa Cruz

  • 2021 Antimicrobial agents and chemotherapy. Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria. Hanh N. Lam, Tannia Lau, Adam Lentz, Jessica Sherry, Alejandro Cabrera-Cortez, Karen Hug, Annalyse Lalljie, Joanne Engel, R. Scott Lokey, Victoria Auerbuch. DOI: https://doi.org/10.1128/AAC.01690-20
  • 2021 International Journal of Cancer. A novel signature predicts recurrence risk and therapeutic response in breast cancer patients. Quynh Hoa Tran,Van Thai Than,Phuc Loi Luu,Declan Clarke,Hanh Ngoc Lam,Thanh-Giang Tan Nguyen,Dinh-Truong Nguyen,Phan Q. Duy,Dung Phung,Minh Nam Nguyen. DOI: https://doi.org/10.1002/ijc.33512
  • 2021 mBio. Genome Scale Analysis Reveals IscR Directly and Indirectly Regulates Virulence Factor Genes in Pathogenic Yersinia. David Balderas, Erin Mettert, Hanh N. Lam, Rajdeep Banerjee, Tomas Gverzdys, Pablo Alvarez, Geetha Saarunya, Natasha Tanner, Adam Zoubedi, Yahan Wei, Patricia J. Kiley, Victoria Auerbuch. DOI: https://doi.org/10.1128/mBio.00633-21
  • 2019 Microbiol Resour Announcement. Complete genome assembly of Yersinia pseudotuberculosis IP2666pIB1. Zoubeidi A, Schwiesow L, Auerbuch V, Lam HN*.Doi: https://doi.org/10.1128/MRA.01592-18
  • 2018 Front. Cell. Infect. Microbiol. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic Yersinia. Jessica M. Morgan, Hanh N. Lam, Jocelyn Delgado, Justin Luu, Sina Mohammadi, Ralph R. Isberg, Helen Wang and Victoria Auerbuch*. DOI: https://doi.org/10.3389/fcimb.2018.00404
  • 2017 Journal of Natural Products. Investigation of the Physical and Bioactive Properties of Bromo- and Iodo-Containing Sponge-Derived Compounds Possessing an Oxyphenylethanamine Core. McCauley EP, Lam H, Lorig-Roach N, Luu J, Lloyd C, Tenney K, Pietraszkiewicz H, Diaz C, Valeriote FA, Auerbuch V, and Crews P. DOI: https://doi.org/10.1021/acs.jnatprod.7b00694
  • 2017 Biomed Mater. Fabrication of a matrigel-collagen semiinterpenetrating scaffold for use in dynamic valve interstitial cell culture. Lam NT, Lam H, Sturdivant NM, Balachandran K*. doi: https://doi.org/10.1088/1748-605X/aa71be
  • 2017 Antimicrob Agents Chemother. Synthetic peptomers as type III secretion system inhibitors. Lam H, Schwochert J, Lao Y, Lau T, Lloyd C, Luu J, Kooner O, Morgan J, Lokey S* and Auerbuch V*. DOI: https://doi.org/10.1128/AAC.00060-17
  • 2017 mSphere. Piericidin A1 Blocks Yersinia Ysc Type III Secretion System Needle Assembly. Morgan JM, Duncan MC, Johnson KS, Diepold A, Lam H, Dupzyk AJ, Martin L, Wong WR, Armitage JP, Linington RG, and Auerbuch V*. DOI: https://doi.org/10.1128/mSphere.00030-17
  • 2015 J Bacteriol. The Yersinia type III secretion system master regulator LcrF. Schwiesow L, Lam H, Dersch P, Auerbuch V*. DOI: https://doi.org/10.1128/JB.00686-15